Furthermore, depletion of LONP1 and ClpP increased cell sensitivity to an SHMT2 inhibitor, suggesting that SHMT2 is a key substrate in the LONP1- and ClpP-mediated proteostasis network and that its protein quality control by mitochondrial proteases may promote cancer cell survival and progression. Here, SHMT2 is linked to cancer.